Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:


Product: Prunelax
Active Ingredient: Senna alexandrina 75mg equivalent to hydroxyanthracenic derivatives (Sennosides B) 15mg
Dosage Form: Film coated tablet
New Zealand Sponsor: CARSL Consulting
Manufacturer: Laboratorios Garden House Farmaceutica S. A., San Bernardo, Chile
Product: Toujeo Max
Active Ingredient: Insulin glargine 300IU/mL equivalent to 10.91mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany

Dated this 10th day of October 2022.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).